Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel antiglaucoma agents jointly disclosed by Ube and Santen

Aug. 18, 2005

Vanilloid VR1 receptor modulators emerge from recent R&D

Aug. 18, 2005

Recent patents cover novel treatments for cognitive disorders

Aug. 18, 2005

Therapeutic agents for arthritis and other musculoskeletal diseases prepared and tested

Aug. 17, 2005

Recent patents reveal novel agents for respiratory diseases

Aug. 17, 2005

New therapeutics for cancer disclosed in recent patent literature

Aug. 17, 2005

New agents for treating obesity disclosed by Procter & Gamble

Aug. 16, 2005

Novel therapeutics for fibroproliferative diseases reported by Scios

Aug. 16, 2005

Recent patents describe new antiinfective agents

Aug. 16, 2005

Novel therapeutics for cardiovascular diseases reported

Aug. 11, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...